{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:46:17Z","timestamp":1791225977905,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81072592"],"award-info":[{"award-number":["81072592"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Basic Research Program","award":["2010CB529800"],"award-info":[{"award-number":["2010CB529800"]}]},{"name":"National Science and Technology major Project","award":["2012ZX09304004"],"award-info":[{"award-number":["2012ZX09304004"]}]},{"DOI":"10.13039\/501100004602","name":"Program for New Century Excellent Talents in University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004602","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Science and Technology Committee","doi-asserted-by":"crossref","award":["11430702200"],"award-info":[{"award-number":["11430702200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Science and Technology Committee","doi-asserted-by":"crossref","award":["12ZR1416300"],"award-info":[{"award-number":["12ZR1416300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Science and Technology Committee","doi-asserted-by":"crossref","award":["12nm0502000"],"award-info":[{"award-number":["12nm0502000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Innovation Program of Shanghai Municipal Education Commission","award":["12ZZ107"],"award-info":[{"award-number":["12ZZ107"]}]},{"name":"SJTU Funding","award":["AE4160003"],"award-info":[{"award-number":["AE4160003"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.biomaterials.2013.02.003","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T12:11:17Z","timestamp":1361967077000},"page":"3870-3881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":202,"title":["Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of\u00a0NAP peptide following intranasal administration"],"prefix":"10.1016","volume":"34","author":[{"given":"Zhongyang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanyin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinguo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2013.02.003_bib1","first-page":"195","article-title":"Neuropathological hallmarks of Alzheimer's disease","volume":"9","author":"Cvetkovi\u0107-Do\u017ei\u0107","year":"2001","journal-title":"Arch Oncol"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib2","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(08)60607-8","article-title":"Alzheimer disease","volume":"42","author":"Smith","year":"1998","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/JAD-2011-101392","article-title":"Dementia, diabetes, Alzheimer's disease, and\u00a0insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics","volume":"25","author":"Kuljis","year":"2011","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib5","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1517\/17425247.2011.588204","article-title":"Intranasal delivery of therapeutic proteins for neurological diseases","volume":"8","author":"Malerba","year":"2011","journal-title":"Expert Opin Drug Deliv"},{"issue":"Suppl. 3","key":"10.1016\/j.biomaterials.2013.02.003_bib6","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2202-9-S3-S5","article-title":"Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9","author":"Hanson","year":"2008","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-8993(95)00637-6","article-title":"Quantitative analysis of the olfactory pathway for drug delivery to the brain","volume":"692","author":"Thorne","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/0022357022539","article-title":"Is nose-to-brain transport of drugs in man a reality?","volume":"56","author":"Illum","year":"2004","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/rej.2010.1130","article-title":"Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease","volume":"14","author":"Danielyan","year":"2011","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib10","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12035-011-8229-6","article-title":"Brain insulin signaling and Alzheimer's disease: current evidence and future directions","volume":"46","author":"Schioth","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib13","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2174\/138161210791164108","article-title":"Potential of nanoparticulate drug delivery systems by intranasal administration","volume":"16","author":"Ali","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/smll.200901158","article-title":"Effect of surface properties on nanoparticle-cell interactions","volume":"6","author":"Verma","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1139\/o01-214","article-title":"Lactoferrin and host defense","volume":"80","author":"Ward","year":"2002","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02018081","article-title":"Structure and biological actions of lactoferrin","volume":"1","author":"Nuijens","year":"1996","journal-title":"J\u00a0Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2008.10.016","article-title":"Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in\u00a0vitro and in\u00a0vivo evaluations","volume":"134","author":"Hu","year":"2009","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.biomaterials.2007.09.024","article-title":"The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain","volume":"29","author":"Huang","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib19","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.biomaterials.2007.04.011","article-title":"Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells","volume":"28","author":"Elfinger","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib20","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1007\/s00018-005-5371-1","article-title":"Mammalian lactoferrin receptors: structure and function","volume":"62","author":"Suzuki","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-0-387-74087-4_6","article-title":"Lactoferrin structure and functions","volume":"606","author":"Legrand","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0165-0173(98)00012-5","article-title":"Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders","volume":"27","author":"Qian","year":"1998","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.lfs.2005.05.085","article-title":"Pharmacokinetics and brain uptake of lactoferrin in rats","volume":"78","author":"Ji","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1385\/JMN:20:3:315","article-title":"From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: a view of neuroprotection and cell division","volume":"20","author":"Gozes","year":"2003","journal-title":"J\u00a0Mol Neurosci"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1385\/JMN:24:1:067","article-title":"NAP mechanisms of neuroprotection","volume":"24","author":"Gozes","year":"2004","journal-title":"J\u00a0Mol Neurosci"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1527-3458.2005.tb00053.x","article-title":"NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP)","volume":"11","author":"Gozes","year":"2005","journal-title":"Cns Drug Rev"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib27","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1046\/j.1471-4159.1999.0721283.x","article-title":"Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide","volume":"72","author":"Bassan","year":"1999","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0167-0115(00)00198-1","article-title":"A\u00a0novel peptide prevents death in enriched neuronal cultures","volume":"96","author":"Zemlyak","year":"2000","journal-title":"Regul Pept"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-3565(24)29662-2","article-title":"A\u00a0peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice","volume":"296","author":"Beni-Adani","year":"2001","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib30","doi-asserted-by":"crossref","first-page":"8543","DOI":"10.1073\/pnas.1331636100","article-title":"Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity","volume":"100","author":"Wilkemeyer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib31","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0022-3565(24)39336-X","article-title":"Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze","volume":"293","author":"Gozes","year":"2000","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery\u2013possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib33","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1016\/j.biomaterials.2006.01.038","article-title":"Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration","volume":"27","author":"Gao","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib34","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1073\/pnas.93.24.14164","article-title":"Brain drug delivery of small molecules using immunoliposomes","volume":"93","author":"Huwyler","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib36","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1023\/A:1019842024814","article-title":"Synthesis of pegylated immunonanoparticles","volume":"19","author":"Olivier","year":"2002","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib37","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.biomaterials.2011.11.018","article-title":"The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles","volume":"33","author":"Xin","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbrc.2008.09.077","article-title":"Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles","volume":"377","author":"Gao","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib39","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1016\/j.biomaterials.2011.07.004","article-title":"Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery","volume":"32","author":"Guo","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib40","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1016\/j.biomaterials.2011.09.004","article-title":"Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration","volume":"32","author":"Xia","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib41","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0196-9781(02)00062-1","article-title":"Amyloid beta-peptide induces cholinergic dysfunction and cognitive deficits: a minireview","volume":"23","author":"Tran","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib42","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nrd2075","article-title":"Drug discovery in dementia: the role of rodent models","volume":"5","author":"Van Dam","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.55782\/ane-2004-1495","article-title":"Alzheimer's disease and acetylcholine receptors","volume":"64","author":"Kihara","year":"2004","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1017\/S1461145705006425","article-title":"Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity","volume":"10","author":"Li","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib45","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ana.410440602","article-title":"Consequences of neonatal seizures in the rat: morphological and behavioral effects","volume":"44","author":"Holmes","year":"1998","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.biomaterials.2013.02.003_bib46","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18433\/J3NC79","article-title":"Intranasal drug delivery: how, why and what for?","volume":"12","author":"Pires","year":"2009","journal-title":"J\u00a0Pharm Pharm Sci"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","article-title":"Nanoparticles for direct nose-to-brain delivery of drugs","volume":"379","author":"Mistry","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijpharm.2007.03.039","article-title":"UEA I-bearing nanoparticles for brain delivery following intranasal administration","volume":"340","author":"Gao","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2011.02.022","article-title":"Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration","volume":"151","author":"Wen","year":"2011","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib50","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/s11095-011-0440-7","article-title":"Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration","volume":"28","author":"Kanazawa","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0278-6915(02)00215-6","article-title":"Purification and acute toxicity of a lectin extracted from tepary bean (Phaseolus acutifolius)","volume":"41","author":"Reynoso-Camacho","year":"2003","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.taap.2010.12.003","article-title":"In\u00a0vivo toxicity and immunogenicity of wheat germ agglutinin conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal delivery to the brain","volume":"251","author":"Liu","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20070507","article-title":"Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study","volume":"407","author":"El-Andaloussi","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tox.2009.09.016","article-title":"Analysis of in\u00a0vitro toxicity of five cell-penetrating peptides by metabolic profiling","volume":"265","author":"Kilk","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib55","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.molmed.2012.04.012","article-title":"Cell-penetrating peptides: breaking through to the other side","volume":"18","author":"Koren","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib56","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0165-6147(02)01989-2","article-title":"The role of the transferrin-transferrin-receptor system in drug delivery and targeting","volume":"23","author":"Li","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/10611860108997935","article-title":"Transport of nanoparticles across the rat nasal mucosa","volume":"9","author":"Brooking","year":"2001","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib58","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1016\/j.biomaterials.2010.06.053","article-title":"Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier","volume":"31","author":"Gan","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib59","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0954-6111(08)80058-3","article-title":"Culture and comparison of human bronchial and nasal epithelial cells in\u00a0vitro","volume":"84","author":"Devalia","year":"1990","journal-title":"Respir Med"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib60","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0005-2736(99)00108-X","article-title":"Cellular internalization of PCL(20)-b-PEO(44) block copolymer micelles","volume":"1421","author":"Allen","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib61","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1016\/j.biomaterials.2011.03.031","article-title":"Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides","volume":"32","author":"Li","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib62","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neubiorev.2004.03.004","article-title":"Regional dissociations within the hippocampus\u2013memory and anxiety","volume":"28","author":"Bannerman","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib63","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib64","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuroscience.2008.01.013","article-title":"Delivery of interferon-beta to the monkey nervous system following intranasal administration","volume":"152","author":"Thorne","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib65","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib66","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00001756-199311180-00018","article-title":"Bilateral injections of beta A(25-35)\u00a0+ IBO into the hippocampus disrupts acquisition of spatial learning in the rat","volume":"5","author":"Dornan","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib67","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0306-4522(97)00507-1","article-title":"Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons","volume":"84","author":"Morimoto","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib68","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0006-8993(03)03173-1","article-title":"Neurotoxicity induced by amyloid beta-peptide and ibotenic acid in organotypic hippocampal cultures: protection by S-allyl-L-cysteine, a garlic compound","volume":"985","author":"Ito","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib69","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0165-0173(01)00067-4","article-title":"Applications of the Morris water maze in the study of learning and memory","volume":"36","author":"D'Hooge","year":"2001","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib70","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1073\/pnas.0408500102","article-title":"Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease","volume":"102","author":"Oddo","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2003.11.021","article-title":"Effects of amyloid-beta on cholinergic and acetylcholinesterase-positive cells in cultured basal forebrain neurons of embryonic rat brain","volume":"998","author":"Kasa","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib72","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1523\/JNEUROSCI.22-08-03234.2002","article-title":"Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis","volume":"22","author":"Boncristiano","year":"2002","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biomaterials.2013.02.003_bib73","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.peptides.2007.08.004","article-title":"NAP protects hippocampal neurons against multiple toxins","volume":"28","author":"Zemlyak","year":"2007","journal-title":"Peptides"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961213001725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961213001725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:47:38Z","timestamp":1758901658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961213001725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":73,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0142961213001725"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.02.003","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of\u00a0NAP peptide following intranasal administration","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}